title: Use of infliximab in a patient with pyoderma gangrenosum and rheumatoid arthritis.
abstract: Pyoderma gangrenosum (PG) is characterized by ulcerative skin lesions. Infliximab (IFX) may promote PG healing in patients with inflammatory bowel disease, but whether IFX is effective for treating PG in patients with rheumatoid arthritis (RA) has not reported. We report the case of a 53-year-old woman with PG complicated by RA who was treated using IFX therapy. This case suggests that IFX therapy might offer effective treatment for such patients.
authors.affiliation: Department of Orthopaedic Surgery, Osaka City University Medical School, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
authors.forename: Masahiro
authors.initials: M
authors.lastname: Tada
authors.forename: Takeshi
authors.initials: T
authors.lastname: Nakanishi
authors.forename: Chika
authors.initials: C
authors.lastname: Hirata
authors.forename: Tadashi
authors.initials: T
authors.lastname: Okano
authors.forename: Yuko
authors.initials: Y
authors.lastname: Sugioka
authors.forename: Shigeyuki
authors.initials: S
authors.lastname: Wakitani
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Nakamura
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Koike
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000187:drug effects / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab